Capital Fund Management S.A. Corcept Therapeutics Inc Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

A detailed history of Capital Fund Management S.A. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Capital Fund Management S.A. holds 149,997 shares of CORT stock, worth $7.63 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

149,997

Previous 93,897 59.75%

Holding current value

$7.63 Million

Previous $3.05 Million 127.48%

% of portfolio

0.02%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$29.51 - $46.26 $1.66 Million - $2.6 Million	56,100 Added 59.75%	149,997 $6.94 Million
Q2 2024 Aug 13, 2024	SELL	$22.21 - $34.48 $872,453 - $1.35 Million	-39,282 Reduced 29.5%	93,897 $3.05 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $1.17 Million - $1.52 Million	55,342 Added 71.1%	133,179 $3.35 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $313,650 - $415,504	12,637 Added 19.38%	77,837 $2.53 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $1.14 Million - $1.76 Million	52,020 Added 394.69%	65,200 $1.78 Million
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $150 - $176	-7 Reduced 0.05%	13,180 $293,000
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $106,329 - $135,514	-5,538 Reduced 29.58%	13,187 $285,000
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $373,563 - $561,001	18,725 New	18,725 $380,000
Q2 2022 Aug 12, 2022	BUY	$17.33 - $25.3 $322,234 - $470,428	18,594 New	18,594 $442,000
Q1 2021 May 14, 2021	SELL	$23.49 - $30.56 $609,917 - $793,490	-25,965 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $162,849 - $264,946	9,705 Added 59.69%	25,965 $679,000
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $202,599 - $324,874	16,260 New	16,260 $283,000
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $111,892 - $185,740	-10,172 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$10.11 - $14.04 $102,838 - $142,814	10,172 New	10,172 $120,000
Q4 2018 Feb 13, 2019	SELL	$11.29 - $17.19 $6.11 Million - $9.3 Million	-540,818 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $2.82 Million - $3.6 Million	229,969 Added 73.98%	540,818 $7.58 Million
Q2 2018 Aug 14, 2018	BUY	$15.3 - $19.69 $2.2 Million - $2.83 Million	143,801 Added 86.08%	310,849 $4.89 Million
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $2.44 Million - $4.26 Million	167,048 New	167,048 $2.75 Million

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.45B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Corcept Therapeutics Inc Transaction History